A Novel Four-Step Regimen is Efficacious in Improving Uneven Skin Tone in Sensitive Skin Patients.

IF 1.8 4区 医学 Q3 DERMATOLOGY Journal of Drugs in Dermatology Pub Date : 2024-12-01 DOI:10.36849/jdd.8220
Thu Q Nguyen, Christine Emesiani, Matthew Meckfessel
{"title":"A Novel Four-Step Regimen is Efficacious in Improving Uneven Skin Tone in Sensitive Skin Patients.","authors":"Thu Q Nguyen, Christine Emesiani, Matthew Meckfessel","doi":"10.36849/jdd.8220","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The appearance of dull skin, uneven skin tone, dark spots, and hyperpigmentation is often bothersome, especially in individuals with darker skin tones. Management of skin dyschromia can be difficult. Several topical ingredients, such as niacinamide and vitamin C, are clinically proven to inhibit pigmentation formation and improve overall skin tone. A skincare regimen formulated to minimize irregular melanin deposition levels has been specifically developed to help improve uneven skin tone for a more radiant appearance. This regimen consists of an exfoliating cleanser (EC), an antioxidant C serum (ACS), a day cream with SPF (DC), and a renewing cream (RC).</p><p><strong>Methods: </strong>A 12-week in-use clinical regimen study was conducted to assess the efficacy, tolerability, and consumer perception of these products on 43 subjects with mild-to-moderate uneven skin tone. Assessments included clinical photography, tolerability, and a self-assessment questionnaire.</p><p><strong>Results: </strong>There was a noticeable improvement in uneven skin tone, as shown in clinical photography across all timepoints (weeks 4, 8, and 12) compared to baseline. The regimen was safe and well tolerated for use and was highly acceptable among the subjects, with 81% of participants agreeing that their skin was more radiant since initiation of the regimen and 76% agreeing that the regimen had helped to significantly reduce the appearance of dark spots after 12 weeks of use. There were no reported adverse events.</p><p><strong>Conclusion: </strong>Overall, these data show that this regimen is effective in reducing the appearance of uneven skin tone. J Drugs Dermatol. 2024;23(12):1072-1075. doi:10.36849/JDD.8220.</p>","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"23 12","pages":"1072-1075"},"PeriodicalIF":1.8000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/jdd.8220","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The appearance of dull skin, uneven skin tone, dark spots, and hyperpigmentation is often bothersome, especially in individuals with darker skin tones. Management of skin dyschromia can be difficult. Several topical ingredients, such as niacinamide and vitamin C, are clinically proven to inhibit pigmentation formation and improve overall skin tone. A skincare regimen formulated to minimize irregular melanin deposition levels has been specifically developed to help improve uneven skin tone for a more radiant appearance. This regimen consists of an exfoliating cleanser (EC), an antioxidant C serum (ACS), a day cream with SPF (DC), and a renewing cream (RC).

Methods: A 12-week in-use clinical regimen study was conducted to assess the efficacy, tolerability, and consumer perception of these products on 43 subjects with mild-to-moderate uneven skin tone. Assessments included clinical photography, tolerability, and a self-assessment questionnaire.

Results: There was a noticeable improvement in uneven skin tone, as shown in clinical photography across all timepoints (weeks 4, 8, and 12) compared to baseline. The regimen was safe and well tolerated for use and was highly acceptable among the subjects, with 81% of participants agreeing that their skin was more radiant since initiation of the regimen and 76% agreeing that the regimen had helped to significantly reduce the appearance of dark spots after 12 weeks of use. There were no reported adverse events.

Conclusion: Overall, these data show that this regimen is effective in reducing the appearance of uneven skin tone. J Drugs Dermatol. 2024;23(12):1072-1075. doi:10.36849/JDD.8220.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一种新的四步疗法对改善敏感皮肤患者不均匀的肤色有效。
背景:皮肤暗沉、肤色不均匀、黑斑和色素沉着往往是令人烦恼的,尤其是肤色较深的人。皮肤染色障碍的管理可能是困难的。一些局部成分,如烟酰胺和维生素C,被临床证明可以抑制色素沉着的形成,改善整体肤色。为了减少不规则的黑色素沉积水平,专门开发了一种护肤方案,以帮助改善不均匀的肤色,使皮肤更有光泽。这个方案包括去角质洗面奶(EC)、抗氧化C血清(ACS)、防晒日霜(DC)和更新霜(RC)。方法:进行了一项为期12周的临床方案研究,以评估43名轻度至中度肤色不均匀的受试者对这些产品的疗效、耐受性和消费者认知。评估包括临床摄影、耐受性和自我评估问卷。结果:与基线相比,所有时间点(第4、8和12周)的临床摄影显示,肤色不均匀的情况有明显改善。该方案是安全且耐受性良好的,并且在受试者中被高度接受,81%的参与者同意自方案开始以来他们的皮肤更有光泽,76%的参与者同意该方案在使用12周后显着减少了黑斑的出现。没有不良事件的报道。结论:总的来说,这些数据表明,该方案是有效的减少肤色不均的出现。皮肤医学杂志,2024;23(12):1072-1075。doi: 10.36849 / JDD.8220。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.20
自引率
13.30%
发文量
289
审稿时长
3-6 weeks
期刊介绍: The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality. Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.
期刊最新文献
Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations. INDIVIDUAL ARTICLE: Real World Use of Topical Tranexamic Acid Serum in Patients With Hyperpigmentation. Rapid Clearance of Lichen Planus With Topical Tapinarof. Objective Measures Needed: Dermatology Program Directors' Perspectives on the USMLE Step 1 Pass/Fail Transition. Patient Interest in Dermatologists in the United States: A 20-Year Google Trends and Workforce Analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1